Sinocare Inc
SZSE:300298

Watchlist Manager
Sinocare Inc Logo
Sinocare Inc
SZSE:300298
Watchlist
Price: 23.29 CNY -5.56% Market Closed
Market Cap: 12.9B CNY
Have any thoughts about
Sinocare Inc?
Write Note

Sinocare Inc
Deferred Income Tax

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Sinocare Inc
Deferred Income Tax Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Deferred Income Tax CAGR 3Y CAGR 5Y CAGR 10Y
Sinocare Inc
SZSE:300298
Deferred Income Tax
ÂĄ39m
CAGR 3-Years
8%
CAGR 5-Years
9%
CAGR 10-Years
N/A
A
APT Medical Inc
SSE:688617
Deferred Income Tax
ÂĄ5.5m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
J
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SZSE:002223
Deferred Income Tax
ÂĄ221.9m
CAGR 3-Years
52%
CAGR 5-Years
44%
CAGR 10-Years
60%
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
Deferred Income Tax
ÂĄ860.8m
CAGR 3-Years
173%
CAGR 5-Years
68%
CAGR 10-Years
N/A
J
Jafron Biomedical Co Ltd
SZSE:300529
Deferred Income Tax
ÂĄ14.1m
CAGR 3-Years
196%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Shanghai United Imaging Healthcare Co Ltd
SSE:688271
Deferred Income Tax
ÂĄ8.8m
CAGR 3-Years
-21%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Sinocare Inc
Glance View

Market Cap
13.1B CNY
Industry
Health Care

Sinocare, Inc. engages in the research, development, manufacture, and commercialization of biosensor-based blood glucose monitoring systems. The company is headquartered in Changsha, Hunan and currently employs 3,534 full-time employees. The company went IPO on 2012-03-19. The firm mainly provides micro blood instant blood sugar monitoring systems including blood sugar testing instruments and related blood sugar testing strips, as well as blood sugar testing systems and mobile blood sugar instruments, among others. The firm also provides diabetes management information systems. The company distributes its products within domestic market and to overseas markets under the brand name of SANNUO.

Intrinsic Value
36.62 CNY
Undervaluation 36%
Intrinsic Value
Price

See Also

What is Sinocare Inc's Deferred Income Tax?
Deferred Income Tax
39m CNY

Based on the financial report for Jun 30, 2024, Sinocare Inc's Deferred Income Tax amounts to 39m CNY.

What is Sinocare Inc's Deferred Income Tax growth rate?
Deferred Income Tax CAGR 5Y
9%

Over the last year, the Deferred Income Tax growth was 10%. The average annual Deferred Income Tax growth rates for Sinocare Inc have been 8% over the past three years , 9% over the past five years .

Back to Top